Mortality within 30 days | Overall mortality | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Group I (Donor age = < 34, N = 132) | Group II (Donor age 35–49, N = 113) | Group III (Donor age 50–64, N = 105) | Group IV (Donor age > = 65, N = 35) | P value | Group I (Donor age = < 34, N = 4723) | Group II (Donor age 35–49, N = 3572) | Group III (Donor age 50–64, N = 3743) | Group IV Donor age (> = 65, N = 1238) | P value | |
Graft failure | 15 (11.4%) | 18 (15.9%) | 13 (12.4%) | 5 (14.3%) | 0.749 | 61 (1.3%) | 60 (1.7%) | 82 (2.2%) | 27 (2.2%) | 0.009 |
Cardiovascular/cerebrovascular | 45 (34.1%) | 38 (33.6%) | 38 (36.2%) | 9 (25.7%) | 0.73 | 128 (2.8%) | 98 (2.7%) | 97 (2.6%) | 33 (2.7%) | 0.98 |
Organ failure | 20 (15.2%) | 14 (12.4%) | 13 (12.4%) | 5 (14.3%) | 0.906 | 112 (2.4%) | 98 (2.7%) | 109 (2.9%) | 54 (4.4%) | 0.002 |
Hemorrhage | 9 (6.8%) | 14 (12.4%) | 10 (9.5%) | 3 (8.6%) | 0.521 | 21 (0.4%) | 26 (0.7%) | 19 (0.5%) | 4 (0.3%) | 0.224 |
Infection | 19 (14.4%) | 13 (11.5%) | 16 (15.2%) | 7 (20%) | 0.631 | 72 (1.5%) | 67 (1.9%) | 97 (2.6%) | 34 (2.7%) | 0.001 |
HCC recurrence | 0 | 0 | 0 | 0 | N/A | 157 (3.3%) | 108 (3.0%) | 109 (2.9%) | 43 (3.5%) | 0.62 |
Others | 24 (18.2%) | 16 (14.2%) | 15 (14.3%) | 6 (17.1%) | 0.797 | 449 (9.5%) | 358 (10.0%) | 376 (10.0%) | 135 (10.9%) | 0.503 |